Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma

BACKGROUND: Patients treated with neoadjuvant chemotherapy (NACT) for advanced high-grade serous ovarian carcinoma (HGSC) have a higher rate and shorter time to platinum-resistant recurrence compared to patients treated with primary cytoreductive surgery (PCS) and adjuvant chemotherapy. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchocki, Zibi, Tone, Alicia, Virtanen, Carl, de Borja, Richard, Clarke, Blaise, Brown, Theodore, May, Taymaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059396/
https://www.ncbi.nlm.nih.gov/pubmed/35501919
http://dx.doi.org/10.1186/s13048-022-00983-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059396/
https://www.ncbi.nlm.nih.gov/pubmed/35501919
http://dx.doi.org/10.1186/s13048-022-00983-5

Ejemplares similares